n-3 fatty acids as preventive and therapeutic agents in attenuating PCOS complications

Mina Salek, Cain Clark, Mohsen Taghizadeh, Sadegh Jafarnejad

Research output: Contribution to journalReview article

1 Downloads (Pure)

Abstract

To our knowledge, in spite of several trials exploring the beneficial effect of n-3 poly unsaturated fatty acids (PUFA) on polycystic ovary syndrome (PCOS), no comprehensive evidence has investigated the effects of n-3 PUFA consumption on PCOS complications. Therefore, our aim was to conduct a review to investigate the possible effect and related mechanisms. A comprehensive systematic search was conducted in Embase, MEDLINE/PubMed, Google Scholar and SCOPUS, to identify studies investigating n-3 fatty acids as a preventative or therapeutic agent for the attenuation of PCOS complications. Subsequently, the impact of omega 3 on PCOS, omega 3 and inflammation, omega 3 and insulin resistance, omega 3 and adipokines, omega 3 and lipid metabolism, omega 3 and endothelial function and omega 3 and hormonal factors were discussed. There are multiple mechanisms by which n-3 PUFAs may exert their beneficial effects on PCOS, including anti-obesity, glycemic and hormonal hemostasis, anti-inflammatory, regulation of adipokine production and enhancement of endothelial function. N-3 PUFAs are a promising agent in relieving complications associated with PCOS. Although most of the studies in patients with PCOS reported an improvement in most complications after administration of omega-3 supplements, there is a distinct dearth of studies investigating the dietary intake of these types of fatty acids. Moreover, favorable effects regarding the improvement of dyslipidemia, regulation of adipokines, regulation of hormonal factors and enhancement of endothelial function are limited. Therefore, more trials are warranted to investigate palatable mechanisms for clarifying the metabolic and hormonal effects of these agents in PCOS.
Original languageEnglish
Pages (from-to)558-575
Number of pages18
JournalEXCLI Journal
Volume18
DOIs
Publication statusPublished - 25 Jul 2019

Fingerprint

Polycystic Ovary Syndrome
Omega-3 Fatty Acids
Adipokines
Therapeutics
Unsaturated Fatty Acids
Dyslipidemias
Hemostasis
Lipid Metabolism
PubMed
MEDLINE
Insulin Resistance
Anti-Inflammatory Agents
Fatty Acids
Obesity
Inflammation

Bibliographical note

This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0/).

Keywords

  • Infertility
  • Metabolic disorder
  • N-3 PUFA
  • Obesity
  • PCOS

ASJC Scopus subject areas

  • Molecular Medicine
  • Animal Science and Zoology
  • Pharmacology
  • Drug Discovery

Cite this

n-3 fatty acids as preventive and therapeutic agents in attenuating PCOS complications. / Salek, Mina ; Clark, Cain; Taghizadeh, Mohsen ; Jafarnejad, Sadegh .

In: EXCLI Journal, Vol. 18, 25.07.2019, p. 558-575.

Research output: Contribution to journalReview article

Salek, Mina ; Clark, Cain ; Taghizadeh, Mohsen ; Jafarnejad, Sadegh . / n-3 fatty acids as preventive and therapeutic agents in attenuating PCOS complications. In: EXCLI Journal. 2019 ; Vol. 18. pp. 558-575.
@article{d313b17806a348eaa2b69fcbd8342c82,
title = "n-3 fatty acids as preventive and therapeutic agents in attenuating PCOS complications",
abstract = "To our knowledge, in spite of several trials exploring the beneficial effect of n-3 poly unsaturated fatty acids (PUFA) on polycystic ovary syndrome (PCOS), no comprehensive evidence has investigated the effects of n-3 PUFA consumption on PCOS complications. Therefore, our aim was to conduct a review to investigate the possible effect and related mechanisms. A comprehensive systematic search was conducted in Embase, MEDLINE/PubMed, Google Scholar and SCOPUS, to identify studies investigating n-3 fatty acids as a preventative or therapeutic agent for the attenuation of PCOS complications. Subsequently, the impact of omega 3 on PCOS, omega 3 and inflammation, omega 3 and insulin resistance, omega 3 and adipokines, omega 3 and lipid metabolism, omega 3 and endothelial function and omega 3 and hormonal factors were discussed. There are multiple mechanisms by which n-3 PUFAs may exert their beneficial effects on PCOS, including anti-obesity, glycemic and hormonal hemostasis, anti-inflammatory, regulation of adipokine production and enhancement of endothelial function. N-3 PUFAs are a promising agent in relieving complications associated with PCOS. Although most of the studies in patients with PCOS reported an improvement in most complications after administration of omega-3 supplements, there is a distinct dearth of studies investigating the dietary intake of these types of fatty acids. Moreover, favorable effects regarding the improvement of dyslipidemia, regulation of adipokines, regulation of hormonal factors and enhancement of endothelial function are limited. Therefore, more trials are warranted to investigate palatable mechanisms for clarifying the metabolic and hormonal effects of these agents in PCOS.",
keywords = "Infertility, Metabolic disorder, N-3 PUFA, Obesity, PCOS",
author = "Mina Salek and Cain Clark and Mohsen Taghizadeh and Sadegh Jafarnejad",
note = "This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/).",
year = "2019",
month = "7",
day = "25",
doi = "10.17179/excli2019-1534",
language = "English",
volume = "18",
pages = "558--575",
journal = "EXCLI Journal",
issn = "1611-2156",
publisher = "University of Mainz",

}

TY - JOUR

T1 - n-3 fatty acids as preventive and therapeutic agents in attenuating PCOS complications

AU - Salek, Mina

AU - Clark, Cain

AU - Taghizadeh, Mohsen

AU - Jafarnejad, Sadegh

N1 - This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/).

PY - 2019/7/25

Y1 - 2019/7/25

N2 - To our knowledge, in spite of several trials exploring the beneficial effect of n-3 poly unsaturated fatty acids (PUFA) on polycystic ovary syndrome (PCOS), no comprehensive evidence has investigated the effects of n-3 PUFA consumption on PCOS complications. Therefore, our aim was to conduct a review to investigate the possible effect and related mechanisms. A comprehensive systematic search was conducted in Embase, MEDLINE/PubMed, Google Scholar and SCOPUS, to identify studies investigating n-3 fatty acids as a preventative or therapeutic agent for the attenuation of PCOS complications. Subsequently, the impact of omega 3 on PCOS, omega 3 and inflammation, omega 3 and insulin resistance, omega 3 and adipokines, omega 3 and lipid metabolism, omega 3 and endothelial function and omega 3 and hormonal factors were discussed. There are multiple mechanisms by which n-3 PUFAs may exert their beneficial effects on PCOS, including anti-obesity, glycemic and hormonal hemostasis, anti-inflammatory, regulation of adipokine production and enhancement of endothelial function. N-3 PUFAs are a promising agent in relieving complications associated with PCOS. Although most of the studies in patients with PCOS reported an improvement in most complications after administration of omega-3 supplements, there is a distinct dearth of studies investigating the dietary intake of these types of fatty acids. Moreover, favorable effects regarding the improvement of dyslipidemia, regulation of adipokines, regulation of hormonal factors and enhancement of endothelial function are limited. Therefore, more trials are warranted to investigate palatable mechanisms for clarifying the metabolic and hormonal effects of these agents in PCOS.

AB - To our knowledge, in spite of several trials exploring the beneficial effect of n-3 poly unsaturated fatty acids (PUFA) on polycystic ovary syndrome (PCOS), no comprehensive evidence has investigated the effects of n-3 PUFA consumption on PCOS complications. Therefore, our aim was to conduct a review to investigate the possible effect and related mechanisms. A comprehensive systematic search was conducted in Embase, MEDLINE/PubMed, Google Scholar and SCOPUS, to identify studies investigating n-3 fatty acids as a preventative or therapeutic agent for the attenuation of PCOS complications. Subsequently, the impact of omega 3 on PCOS, omega 3 and inflammation, omega 3 and insulin resistance, omega 3 and adipokines, omega 3 and lipid metabolism, omega 3 and endothelial function and omega 3 and hormonal factors were discussed. There are multiple mechanisms by which n-3 PUFAs may exert their beneficial effects on PCOS, including anti-obesity, glycemic and hormonal hemostasis, anti-inflammatory, regulation of adipokine production and enhancement of endothelial function. N-3 PUFAs are a promising agent in relieving complications associated with PCOS. Although most of the studies in patients with PCOS reported an improvement in most complications after administration of omega-3 supplements, there is a distinct dearth of studies investigating the dietary intake of these types of fatty acids. Moreover, favorable effects regarding the improvement of dyslipidemia, regulation of adipokines, regulation of hormonal factors and enhancement of endothelial function are limited. Therefore, more trials are warranted to investigate palatable mechanisms for clarifying the metabolic and hormonal effects of these agents in PCOS.

KW - Infertility

KW - Metabolic disorder

KW - N-3 PUFA

KW - Obesity

KW - PCOS

UR - http://www.scopus.com/inward/record.url?scp=85070226854&partnerID=8YFLogxK

U2 - 10.17179/excli2019-1534

DO - 10.17179/excli2019-1534

M3 - Review article

VL - 18

SP - 558

EP - 575

JO - EXCLI Journal

JF - EXCLI Journal

SN - 1611-2156

ER -